Ekso Bionics Holdings, Inc. (EKSO) - Comprehensive Stock Analysis & Investment Research
Deep dive into Ekso Bionics Holdings, Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.
Ekso Bionics Holdings, Inc. Investment Summary
When evaluating whether Ekso Bionics Holdings, Inc. (EKSO) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.
Company Profile
Ekso Bionics Holdings, Inc. (EKSO) operates within the Technology sector, specifically in the General Industrial Machinery & Equipment, NEC industry. The company employs approximately 116 people. With a market capitalization of $36 million, the company is a small-cap stock that may offer higher growth potential but also carries higher volatility.
Financial Performance Analysis
Our comprehensive financial analysis covers Ekso Bionics Holdings, Inc.'s revenue, profitability metrics, balance sheet strength, and cash flow generation...
AI Price Predictions
Get AI-powered 7-day, 30-day and 90-day price forecasts for Ekso Bionics Holdings, Inc. along with confidence scores and detailed analysis...
Investment Considerations
Expert analysis of whether Ekso Bionics Holdings, Inc. is suitable for your investment objectives, risk tolerance, and time horizon...
Corporate Identity
Ekso Bionics Holdings, Inc. (Stock Symbol: EKSO) is a prominent company operating within the Technology sector, with a specific focus on the General Industrial Machinery & Equipment, NEC industry. The company's shares are publicly traded on the Nasdaq exchange.
Leadership & Workforce
Detailed information about Ekso Bionics Holdings, Inc.'s leadership team, workforce size, and organizational structure...
Market Classification
Market capitalization analysis and stock classification (mega-cap, large-cap, mid-cap, small-cap) for Ekso Bionics Holdings, Inc....
Sector & Industry Analysis
In-depth sector dynamics and industry context for Ekso Bionics Holdings, Inc....
Revenue & Growth Analysis
Ekso Bionics Holdings, Inc. generates annual revenues of $2 million , representing an emerging company in its growth phase.
Profitability Metrics
Net profit margin, gross margin, and operating margin analysis for Ekso Bionics Holdings, Inc....
Market Valuation
P/E ratio, price-to-book, and valuation multiples for Ekso Bionics Holdings, Inc....
Return Metrics
Return on equity (ROE), return on assets (ROA), and capital efficiency for Ekso Bionics Holdings, Inc....
Strategic Market Position
Ekso Bionics Holdings, Inc. strategically competes in the highly dynamic General Industrial Machinery & Equipment, NEC marketplace. As a small-cap company, it represents an emerging market participant with potentially significant growth opportunities. Small-caps often offer greater growth potential as they capture market share and scale their operations, though this comes with higher risk and volatility. Success at this stage can lead to substantial returns for early investors who identify winning business models.
Industry Competitive Landscape
Ekso Bionics Holdings, Inc. operates within the fast-evolving technology sector where competitive dynamics are shaped by innovation cycles, platform economics, and network effects. Technology companies must continuously invest in R&D to maintain relevance, while also defending against disruption from startups and adjacent market entrants. Success in this sector often requires achieving critical scale or establishing defensible intellectual property positions.
Operational Efficiency
The company currently shows negative free cash flow of $-13 million , with year-over-year cash flow growth of 96.2%. Negative free cash flow may reflect heavy investment in growth, working capital needs, or operational challenges. This is common for high-growth companies investing aggressively but warrants attention for mature businesses.
Margin & Pricing Power Analysis
The company maintains a 364.0% gross margin which reflects exceptional pricing power and/or an asset-light business model. Gross margins at this level are typically seen in software, pharmaceuticals, or luxury goods companies where the cost of incremental production is minimal relative to selling prices. Such margins indicate significant competitive advantages protecting the company from price-based competition.
Operating margin of -463.8% demonstrates how efficiently the company converts revenues into operating profits after accounting for all operating expenses including research and development, sales and marketing, and general administrative costs. Operating margin compression relative to gross margin suggests high operating expenses that may warrant efficiency improvements or reflect necessary growth investments.
Asset Utilization Efficiency
Asset turnover ratio of 0.24x indicates lower asset turnover that may reflect the industry's capital-intensive nature or potentially underutilized assets. Companies with low turnover typically depend on strong margins to generate adequate returns on capital.
Financial Strength & Leverage
Current ratio of 7.22 demonstrates strong short-term liquidity with current assets significantly exceeding current liabilities. This provides a substantial buffer for meeting near-term obligations and handling unexpected financial needs.